FABP5 Inhibition against PTEN-Mutant Therapy Resistant Prostate Cancer.
Cancers (Basel)
; 16(1)2023 Dec 21.
Article
en En
| MEDLINE
| ID: mdl-38201488
FABP5; PTEN tumor suppressor; RapidCaP; SBFI-103; androgen deprivation therapy (ADT); apalutamide resistance; castration-resistant prostate cancer (CRPC); enzalutamide resistance; fatty acid binding proteins (FABPs); genetically engineered mouse (GEM) models of human cancer; lipid signaling; metastatic castration-resistant prostate cancer (mCRPC); prostate cancer (PC); taxane resistance
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Idioma:
En
Revista:
Cancers (Basel)
Año:
2023
Tipo del documento:
Article
País de afiliación:
Estados Unidos